Literature DB >> 15475070

Clinicopathological features and prognostic factors of Japanese patients with "peripheral T-cell lymphoma, unspecified" diagnosed according to the WHO classification.

Hiroshi Kojima1, Yuichi Hasegawa, Kazumi Suzukawa, Harumi Y Mukai, Shin Kaneko, Toshitaka Kobayashi, Masaharu Kamoshita, Atsushi Shinagawa, Takuya Komeno, Tsunehiko Komatsu, Shoichi Mitsuhashi, Yasuhiro Kawachi, Yoriko Yamashita, Naoyoshi Mori, Toshiro Nagasawa.   

Abstract

Clinicopathological features of 36 patients, male: 58.3%; median: 68 years, with "peripheral T-cell lymphoma, unspecified" diagnosed by the WHO criteria were reviewed. Majority (69.4%) had stage IV disease with frequent involvements into bone marrow, spleen, liver, and skin. According to the IPI, 72.2% were categorized as high or high-intermediate risk group. CR and PR were achieved in 12 and 10 out of 31 patients treated by CHOP-based chemotherapy, respectively. One- and two-year overall survivals were 60.6 and 25.0%, respectively. Performance status, serum LDH, and B symptom were significant prognostic factors. Survival of CD4-/CD8+ cases, corresponding to cytotoxic T-cell lymphoma, was significantly worse than that of CD4+/CD8-.

Entities:  

Mesh：

Year:  2004        PMID： 15475070     DOI： 10.1016/j.leukres.2004.04.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  11 in total

1.  Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508.

Authors:  Yoshitoyo Kagami; Kuniaki Itoh; Kensei Tobinai; Haruhiko Fukuda; Kiyoshi Mukai; Takaaki Chou; Chikara Mikuni; Tomohiro Kinoshita; Noriyasu Fukushima; Yoshio Kiyama; Takayo Suzuki; Tsuneo Sasaki; Yuko Watanabe; Kunihiro Tsukasaki; Tomomitsu Hotta; Masanori Shimoyama; Michinori Ogura
Journal:  Int J Hematol       Date:  2012-06-03       Impact factor: 2.490

Review 2.  New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.

Authors:  Kieron Dunleavy; Richard L Piekarz; Jasmine Zain; John E Janik; Wyndham H Wilson; Owen A O'Connor; Susan E Bates
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

3.  A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.

Authors:  Yoshihiro Torimoto; Kazuya Sato; Katsuya Ikuta; Toshiaki Hayashi; Yasuo Hirayama; Junki Inamura; Hajime Kobayashi; Ryoji Kobayashi; Kyuhei Koda; Mitsutoshi Kurosawa; Akio Mori; Shuichi Ota; Hajime Sakai; Akio Shigematsu; Motohiro Shindo; Hitoshi Shinzaki; Fumihiko Takahashi; Rishu Takimoto; Junji Tanaka; Satoshi Yamamoto; Yutaka Kohgo; Takashi Fukuhara
Journal:  Int J Hematol       Date:  2013-06-29       Impact factor: 2.490

4.  Peripheral T-cell lymphoma presenting as an ischemic stroke in a 23-year-old woman: a case report and review of the literature.

Authors:  Mariantina Fragou; Dimitrios Karakitsos; Alexandros Kalogeromitros; George Samonis; Andreas Karabinis
Journal:  J Med Case Rep       Date:  2009-10-27

5.  Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project.

Authors:  Eric D Hsi; Jonathan Said; William R Macon; Scott J Rodig; Sarah L Ondrejka; Randy D Gascoyne; Elizabeth A Morgan; David M Dorfman; Matthew J Maurer; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

6.  Clinical analysis and prognostic significance of L-asparaginase containing multidrug chemotherapy regimen in incipient peripheral T-cell lymphoma.

Authors:  Guoli Yao; De Zhou; Meng Zhou; Changqian Bao; Donghua He; Li Li; Jingjing Zhu; Jinsong He; Jimin Shi; Weiyan Zheng; Zhen Cai; He Huang; Xiujin Ye; Wanzhuo Xie
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma.

Authors:  Wanzhuo Xie; Keyue Hu; Fan Xu; De Zhou; Jingsong He; Jimin Shi; Yi Luo; Jingjing Zhu; Jie Zhang; Maofang Lin; Xiujin Ye; He Huang; Zhen Cai
Journal:  Ann Hematol       Date:  2012-12-13       Impact factor: 3.673

Review 8.  Prognostic markers in peripheral T-cell lymphoma.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Anna Gazzola; Claudia Mannu; Francesco Bacci; Elena Sabattini; Stefano A Pileri
Journal:  Curr Hematol Malig Rep       Date:  2010-10       Impact factor: 3.952

9.  Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.

Authors:  Catalina Amador; Timothy C Greiner; Tayla B Heavican; Lynette M Smith; Karen Tatiana Galvis; Waseem Lone; Alyssa Bouska; Francesco D'Amore; Martin Bjerregaard Pedersen; Stefano Pileri; Claudio Agostinelli; Andrew L Feldman; Andreas Rosenwald; German Ott; Anja Mottok; Kerry J Savage; Laurence de Leval; Philippe Gaulard; Soon Thye Lim; Choon Kiat Ong; Sarah L Ondrejka; Joo Song; Elias Campo; Elaine S Jaffe; Louis M Staudt; Lisa M Rimsza; Julie Vose; Dennis D Weisenburger; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2019-12-12       Impact factor: 25.476

Review 10.  Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Authors:  C Agostinelli; P P Piccaluga; P Went; M Rossi; A Gazzola; S Righi; T Sista; C Campidelli; P L Zinzani; B Falini; S A Pileri
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.